Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (321-330 of 405) with videos related to

Pageof 41
Sort By:
Revista Espanola De Cardiologia (English Ed.)|January 1, 2017
2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTSPaulus Kirchhof, Stefano Benussi, Dipak Kotecha, et al.
International Journal of Cardiology|April 13, 2013
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromesRenato D Lopes, Jennifer A White, Dan Atar, et al.
Journal of the American College of Cardiology|February 7, 2024
Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary DiseaseDaniel J McClintick, Michelle L O'Donoghue, Gaetano M De Ferrari, et al.
European Heart Journal|August 28, 2016
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSPaulus Kirchhof, Stefano Benussi, Dipak Kotecha, et al.
American Heart Journal|November 18, 2020
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and designAnna M Nordenskjöld, Stefan Agewall, Dan Atar, et al.
Journal of the American College of Cardiology|September 24, 2013
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarinZiad Hijazi, Lars Wallentin, Agneta Siegbahn, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 20, 2013
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General RegistryGregory Y H Lip, Cécile Laroche, Gheorghe-Andrei Dan, et al.
Circulation|February 19, 2019
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body WeightStefan H Hohnloser, Marat Fudim, John H Alexander, et al.
European Heart Journal|September 16, 2015
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trialDragos Vinereanu, Susanna R Stevens, John H Alexander, et al.
Heart (British Cardiac Society)|June 26, 2015
Characterising and predicting bleeding in high-risk patients with an acute coronary syndromeRazi Khan, Renato D Lopes, Megan L Neely, et al.
Pageof 41

Showing results (321-330 of 405) with videos related to

Sort By:
Pageof 41
Revista Espanola De Cardiologia (English Ed.)|January 1, 2017
2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTSPaulus Kirchhof, Stefano Benussi, Dipak Kotecha, et al.
International Journal of Cardiology|April 13, 2013
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromesRenato D Lopes, Jennifer A White, Dan Atar, et al.
Journal of the American College of Cardiology|February 7, 2024
Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary DiseaseDaniel J McClintick, Michelle L O'Donoghue, Gaetano M De Ferrari, et al.
European Heart Journal|August 28, 2016
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSPaulus Kirchhof, Stefano Benussi, Dipak Kotecha, et al.
American Heart Journal|November 18, 2020
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and designAnna M Nordenskjöld, Stefan Agewall, Dan Atar, et al.
Journal of the American College of Cardiology|September 24, 2013
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarinZiad Hijazi, Lars Wallentin, Agneta Siegbahn, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 20, 2013
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General RegistryGregory Y H Lip, Cécile Laroche, Gheorghe-Andrei Dan, et al.
Circulation|February 19, 2019
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body WeightStefan H Hohnloser, Marat Fudim, John H Alexander, et al.
European Heart Journal|September 16, 2015
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trialDragos Vinereanu, Susanna R Stevens, John H Alexander, et al.
Heart (British Cardiac Society)|June 26, 2015
Characterising and predicting bleeding in high-risk patients with an acute coronary syndromeRazi Khan, Renato D Lopes, Megan L Neely, et al.
Pageof 41